An allele is not a genotype, though the two are tightly linked. An allele is one version of a gene, while a genotype is the specific pair (or set) of alleles you carry at a given gene location. Think of it this way: if alleles are individual playing cards, your genotype is the hand you were dealt. The distinction sounds like semantics, but it shapes everything from how genetic diseases are diagnosed to how your traits actually show up.
How They Relate Without Being the Same Thing
Every gene occupies a fixed position on a chromosome, and for most genes in humans, you carry two copies because your chromosomes come in pairs, one from each biological parent. Each copy can be the same version of the gene or a different version. Those individual versions are alleles. Your genotype at that gene is whichever combination of alleles you ended up with.
When both alleles match, the genotype is called homozygous. When they differ, it is called heterozygous. A person who carries two copies of the same hemoglobin allele has a homozygous genotype at that location. Someone who inherited one normal hemoglobin allele and one sickle-cell allele has a heterozygous genotype. In both cases, the alleles are the ingredients; the genotype is the recipe card that lists which ingredients are present.
The terms “gene,” “allele,” and “genotype” were not even coined until the early 1900s, decades after Gregor Mendel first described the patterns of heredity in 1865. The word “genetics” itself dates to 1906, and the formal concepts of genotype and phenotype were introduced around the same time as scientists worked to build a general science of heredity on top of Mendel’s crossing experiments.1PubMed. From Mendel to epigenetics: History of genetics So the vocabulary is just over a century old, and the confusion between the terms is almost as old as the terms themselves.
From Genotype to What You Actually See
The reason the distinction matters beyond vocabulary is that your genotype at a gene determines your phenotype for the trait that gene influences. Phenotype is just the observable outcome: your blood type, your eye color, whether a particular enzyme works properly. Two people can carry different genotypes and still show the same phenotype if one allele is dominant over the other. In that case, a person who is homozygous for the dominant allele and a person who is heterozygous will look the same on the outside, even though their underlying genotypes differ.
Dominance itself is not a simple on-off switch. Research across many species shows that phenotypic dominance emerges from departures from a simple straight-line relationship between genotype and phenotype at various biological levels, from molecules to whole organisms.2PubMed Central. The integrative biology of genetic dominance In other words, dominance is not a property stamped on an allele like a label. It is an outcome of how the entire biological system processes the information carried by that allele in combination with the other allele present. Two alleles that produce nearly the same amount of a protein might show incomplete dominance, giving a blended phenotype. Others interact in ways that are not blended at all, producing entirely novel outcomes in the heterozygote. The point is that knowing someone’s alleles is not enough. You need to know the genotype, the combination, and then you need to understand how that combination plays out through the body’s machinery before you can predict the trait.
When Two Different Broken Alleles Team Up
One of the most clinically significant reasons to distinguish alleles from genotypes is compound heterozygosity. In this situation, a person inherits two different mutant alleles of the same gene, one from each parent. Neither parent is sick because each carries only one mutant allele alongside a working copy. But the child who ends up with two different broken versions, and no working copy, can develop disease.
Autosomal recessive polycystic kidney disease provides a real example. In one Chinese family, researchers identified two novel mutations in the PKHD1 gene in the affected child. One mutation was inherited from the mother and the other from the father. Neither parent had the disease, but the child’s genotype, carrying both mutations with no normal allele to compensate, caused the condition.3PubMed Central. Novel compound heterozygous PKHD1 mutations cause autosomal recessive polycystic kidney disease in a Han Chinese family If you only looked at each allele in isolation, you would see two different rare variants that each look benign in a carrier. It is only the genotype, the specific combination, that creates the problem.
This is also why genetic counseling does not stop at identifying a single allele. Knowing that someone carries one copy of a disease-associated allele tells you they are a carrier. Knowing their full genotype at that gene tells you whether they are affected, at risk, or simply carrying a variant that could matter in the next generation.
Genes on the X Chromosome Play by Different Rules
The tidy picture of two alleles per gene falls apart when you look at the X chromosome in males. Males typically carry one X and one Y chromosome. For most genes on the X, there is no matching copy on the Y. That means males have only one allele at those gene locations, a state called hemizygosity. There is no second allele to form a genotype in the usual sense, so the single allele’s effect is fully exposed.
This has real consequences. Research on X-linked variants has shown that pathogenic alleles on the X chromosome tend to hit hemizygous males harder than heterozygous females, because females still have a second X that can compensate. One study found that for variants classified as the most damaging, the ratio of females to males carrying those alleles was significantly elevated, consistent with the idea that males carrying those same alleles were less likely to survive to be counted.4PubMed Central. Hemizygosity Can Reveal Variant Pathogenicity on the X-Chromosome In the non-matching regions of the X chromosome, the most harmful variants showed an average female-to-male ratio above 3, compared to about 2.4 for benign reference variants.
For females, the genotype concept works normally on the X: they can be homozygous or heterozygous. For males, the concept of “genotype at this locus” reduces to a single allele. It is still a genotype in the formal sense, a description of which alleles are present, but the biological stakes are different because there is no partner allele to buffer the effect.
Mitochondrial DNA Has Its Own System
The allele-and-genotype framework was built around the DNA in your cell nucleus, which sits on chromosomes in neat pairs. But your cells also carry a small, separate genome inside the mitochondria, the structures that generate energy. Mitochondrial DNA does not follow the same inheritance rules. You inherit it almost exclusively from your mother, and each cell carries hundreds or thousands of copies rather than just two.
When all those copies are identical, the situation is straightforward. But when a mutation arises in some copies and not others, the cell ends up with a mixture of mitochondrial alleles, a condition called heteroplasmy. Nearly everyone harbors at least some heteroplasmic variants. A large genetic study found that heteroplasmic single-nucleotide variants tend to arise during a person’s lifetime and accumulate sharply after age 70, while heteroplasmic insertions and deletions are more often maternally inherited as mixtures whose levels are influenced by dozens of nuclear genes.5Nature. Nuclear genetic control of mtDNA copy number and heteroplasmy in humans
This creates a situation where the standard allele-genotype vocabulary barely applies. You do not have two alleles at a mitochondrial gene; you might have thousands of copies with varying proportions of different versions. Mitochondrial heteroplasmy exists as a dynamic mix of inherited variants and somatic mutations in varying ratios, often with repetitive patterns of tissue specificity, meaning your heart cells might carry a different ratio than your liver cells.6PubMed Central. Mitochondrial DNA heteroplasmy in human health and disease In insect populations, researchers have even documented how heteroplasmic individuals transmit their resistant and susceptible mitochondrial alleles to offspring in highly variable ratios, demonstrating that mitochondrial inheritance does not follow Mendelian rules at all.7PubMed Central. Mitochondrial heteroplasmy and the evolution of insecticide resistance: non-Mendelian inheritance in action
For the nuclear genome, asking “what is your genotype?” has a stable answer that does not change over your lifetime. For mitochondrial DNA, the answer can shift as you age, and it can differ between your organs.
When Different Cells in Your Body Carry Different Genotypes
Even within your nuclear genome, the assumption that every cell in your body carries the same genotype is an oversimplification. From the moment a fertilized egg begins dividing, mutations can occur in individual cells. If those cells keep dividing, entire lineages of cells end up carrying genetic changes that their neighbors do not. The result is somatic mosaicism: one person harboring multiple genetically distinct cell populations.8PubMed. Somatic mosaicism in healthy human tissues
Somatic mosaicism is not rare or exotic. It refers to the occurrence of two or more genetically distinct populations of cells within an individual, all derived from mutations that happened after the initial fertilization event.9PubMed Central. Somatic mosaicism in the human genome When geneticists talk about “your genotype,” they typically mean the genotype found in the majority of your cells, or the genotype in whichever tissue was sampled for a genetic test, usually blood or saliva. But a skin biopsy might reveal a different genotype at a particular locus than a blood test would, especially for variants that arose during embryonic development.
This matters practically. A person might test negative for a variant on a standard blood-based genetic test, yet still carry it in other tissues. In clinical settings, somatic mosaicism can explain puzzling cases where someone shows partial symptoms of a genetic condition that their blood test says they should not have. It also means that the sharp categories of homozygous and heterozygous, built for a world where every cell matches, get blurrier when you look closely enough.
Same Alleles, Different Outcomes Through Epigenetics
There is yet another layer that complicates the relationship between alleles and observable traits. Two organisms can share identical DNA sequences at a gene, identical alleles, and therefore identical genotypes, yet still show different phenotypes. The cause is epigenetic modification: chemical tags on the DNA or its packaging proteins that affect whether a gene is active or silent, without changing the underlying sequence.
In mammals, certain genomic regions called metastable epialleles show variable DNA methylation states between genetically identical individuals.10PubMed. Metastable epialleles and their contribution to epigenetic inheritance in mammals The classic example involves genetically identical mice that differ dramatically in coat color and body weight purely because of how methylated a particular region is. In plants, heritable phenotypic differences caused by epigenetic modifications rather than DNA sequence mutations have been documented extensively, challenging the assumption that all heritable variation comes from allelic differences.11PubMed Central. Epialleles in plant evolution
What this means for the allele-genotype distinction is that genotype alone does not always predict phenotype, even in theory. Two people with the same genotype at a gene can express it differently because of epigenetic marks that are not captured by standard sequencing. This is why some researchers now speak of “epialleles,” versions of a gene defined not by sequence but by methylation or other chemical modifications. It is a reminder that “genotype” as traditionally defined captures a lot, but not everything, about how genes shape traits.
How Sequencing Technology Actually Reads Your Genotype
When a lab reports your genotype, what they are really doing is reading the DNA sequence at specific positions and calling which alleles are present. This sounds straightforward, but accuracy depends heavily on how deeply the DNA is read. Modern whole-genome sequencing works by reading the same stretch of DNA many times over, and the more times it reads, the more confident the call.
An evaluation of variant-calling accuracy using ultra-deep sequencing found that achieving over 99 percent concordance with known genotypes required a minimum depth of about 14 reads for most variants, and roughly 19 reads for heterozygous genotypes specifically.12PubMed Central. Empirical evaluation of variant calling accuracy using ultra-deep whole-genome sequencing data Heterozygous genotypes are harder to call because the two alleles contribute roughly equal numbers of reads, and at low depth, random sampling can make it look like only one allele is present. This is a practical echo of the allele-genotype distinction: the technology has to detect each individual allele before it can assemble the genotype, and missing one allele means reporting the wrong genotype entirely.
In pharmacogenomics, which uses genetic information to guide drug prescriptions, a related problem has emerged with star-allele nomenclature. This system labels common allele combinations with star numbers (like *1 for the normal allele, *2 for a common variant, and so on). A study of 25 pharmacogenes found that roughly 41 percent of star alleles identified across a global sample did not fit neatly into the expected groupings, often because they were defined by a single variant rather than a distinct haplotype.13PubMed Central. Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants The labeling system that was supposed to streamline the jump from alleles to genotypes to drug recommendations sometimes introduces its own confusion.
Why Evolution Cares About Both Levels
Natural selection does not operate on alleles or genotypes in isolation. It acts on organisms, which carry genotypes, which produce phenotypes, which determine survival and reproduction. But measuring selection requires researchers to track changes at multiple levels. Patterns of DNA variability reveal which alleles are spreading or vanishing in a population. Spatial and temporal shifts in allele frequencies show where and when selection is acting. And fitness estimates tied to specific phenotypes reveal why certain traits are favored.14PubMed Central. Measuring natural selection on genotypes and phenotypes in the wild
From evolution’s perspective, alleles are what get passed down. Genotypes are what get assembled fresh in each generation, shuffled by the randomness of which allele from each parent ends up in each offspring. An allele that is harmful in one genotypic context, paired with a particular partner allele, might be neutral or even beneficial in another. Sickle-cell trait is the textbook example: one copy of the sickle-cell allele in a heterozygous genotype confers some resistance to malaria, while two copies in a homozygous genotype cause disease. Selection acts on the genotype-level outcome, but what persists across generations is the allele.
This is perhaps the deepest reason the allele-genotype distinction is not just vocabulary housekeeping. Alleles are the units of inheritance, the things that get copied and transmitted. Genotypes are the units of expression, the combinations that actually produce effects in a living body. Confusing the two is like confusing a musical note with a chord. The note exists on its own and can be written down. But what you hear, and what matters for the music, depends on which notes are played together.